Back to company

ACUPHARMA ApS: Financial statements 2020

CVR: 10072956

ACUPHARMA ApS (CVR 10072956) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 1,367,554 and a net result of DKK -234,576 compared with DKK 32,839 the year before. That is a decrease of 18.8% compared with the year before. Equity amounted to DKK 152,230. The solvency ratio was 6%. The company had 3 employees in the financial year.

Gross Profit
1,367,554 kr.
Profit/Loss
-234,576 kr.
Equity
152,230 kr.
Total Assets
2,550,285 kr.
Employees
3

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2020-1.4 mio.-235 t.152 t.3
2019-1.7 mio.33 t.387 t.4
2018-1.7 mio.5 t.154 t.-
2017-1.5 mio.80 t.149 t.-
2016-1.1 mio.10568 t.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is ACUPHARMA ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2020

ACUPHARMA ApS: The 2019 annual report is outMar 13, 2020

ACUPHARMA ApS has published its annual report for 2019. Gross profit came to DKK 1,684,289, and the net result was DKK 32,839.

About ACUPHARMA ApS

ACUPHARMA ApS is a Danish company of the type Anpartsselskab based in Roskilde, founded in 2001. The company is registered under the industry Engroshandel med andre fødevarer. The management consists of Christina Uekermann Skive and Jeanne Helsted. The company is owned by SKIVE & HELSTED A/S. The company has 5 employees. In 2025, the company reported a gross profit of DKK 1,150,834 and a net result of DKK 287,572 compared with DKK -258,766 the year before. Equity amounted to DKK -109,301.